Drug Shortage Report for CEFAZOLIN FOR INJECTION USP

Last updated on 2025-12-01 History
Report ID 269388
Drug Identification Number 02308967
Brand name CEFAZOLIN FOR INJECTION USP
Common or Proper name CEFAZOLIN FOR INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10PSOIJ
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-10-14
Estimated end date 2025-11-28
Actual end date 2025-11-28
Shortage status Resolved
Updated date 2025-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-12-01 French Compare
v9 2025-12-01 English Compare
v8 2025-11-17 French Compare
v7 2025-11-17 English Compare
v6 2025-11-03 French Compare
v5 2025-11-03 English Compare
v4 2025-10-15 English Compare
v3 2025-10-14 French Compare
v2 2025-10-14 English Compare
v1 2025-10-14 English Compare

Showing 1 to 10 of 10